Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Veoneer and emotion3D recognized for “Most Innovative In-Cabin Perception Application”

Stockholm, Sweden, September 16, 2022: The AutoSens Award celebrates the best and brightest working at the cutting-edge of innovation in ADAS and autonomous vehicle technology. At the event in Brussels earlier this week, Veoneer and emotion3D were honored with the AutoSens Award in the category Most Innovative In-Cabin Perception Application.It is a fact that a car crash impacts people in different ways as body factors play a role in accident injury severity. In fact, a female occupant is 73% more likely to suffer from serious injuries than seatbelt-wearing male occupants, according to the

Investment in new machinery accelerates Wellspect road to net-zero

In support of Wellspect’s ambition to become a climate neutral business, a switch to more sustainable machinery that operates on more climate-friendly technology, is taking place. This week, Wellspect received and installed the first in a series of cooling machines that will see to a reduction of its environmental footprint. The new cooling machine is part of a larger project seeking to replace the cooling systems at its biggest production plant in Mölndal, Sweden. The new units, which rely on the ammonia refrigerant, enable an annual decrease of 200 ton of CO2e, when compared to

BioStock: Aptahem on the importance of raising sepsis awareness

Sepsis is a life-threatening condition. Every year, 50 million people are affected by sepsis, of which 11 million die.Despite this, a targeted treatment is still missing. Today, September 16, a seminar will be held in Berlin to draw attention to the consequences of sepsis and BioStock has spoken to Ingela Hallberg, licensed physician and CMO at Aptahem, a biotech developing a new treatment specifically for sepsis but also other severe inflammatory conditions.Read the full interview with Aptahem´s CMO Ingela Hallberg at biostock.se: https://www.biostock.se/en/2022/09/aptahem-on-the-

All-time high sales of hydrogen at Høvik fueling station

Hynion's hydrogen station at Høvik has just completed its busiest month ever.  The sales of hydrogen fuel for private cars and taxis have more than doubled since the turn of the year.  The increased demand for hydrogen has even created queues for filling up hydrogen cars.  Last week, Hynion significantly improved the fueling station's capacity by installing a new and powerful compressor.  Refuelling takes place in a few minutes, and the volumes delivered from the station are three times higher than last year.The substantial improvement in capacity helps an ever-increasing taxi fleet to

Sensys Gatso receives an order from Ecuador, worth SEK 20 million

Sensys Gatso Group, a global leader in traffic safety solutions, through its subsidiary Sensys Gatso LATAM, has received an order for the supply and support of traffic enforcement systems from its partner to be implemented in the municipalities of Mancomunidad and Santa Elena, Ecuador. The order has a value of approximately SEK 20 million. This is the second order for Sensys Gatso in Ecuador, in the strategic LATAM Region, after the Duran project.The Municipalities of Mancomunidad and Santa Elena in Ecuador and our partner are cooperating in a consortium to implement a comprehensive traffic

SkartaNYAB Oyj - Managers' Transactions

SkartaNYAB PlcMANAGERS' TRANSACTIONS16 September 2022 at 09:45SkartaNYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Andament Group OyPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In IssuerName: Jukka JuolaPosition: Member of the Board (2):Person Discharging Managerial Responsibilities In IssuerName: Markku KankaalaPosition: Member of the Board Issuer: SkartaNYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL

Teleperformance earns second consecutive Great Place to Work® award in Finland

STOCKHOLM, 16 SEPTEMBER 2022 – Teleperformance, a leading global group in digitally integrated business services, announced that its operations in Finland received the prestigious Great Place to Work® (GPTW®) certification for the second consecutive year.A global authority on workplace culture, Great Place to Work® provides independent company assessments based entirely on employees’ feedback about their workplace experience. Highlights from the survey result show that over 91% percent feel that they are treated fairly regardless of gender, sexual orientation or age, with 97% who feel

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release September 16, 2022 at 9:30 a.m. Nokian Tyres has received an announcement from JPMorgan Chase & Co. on September 15, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total holding in Nokian Tyres shares owned by the funds and accounts managed by JPMorgan Chase & Co. fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on September 14, 2022. Total positions of person(s) subject to the notification obligation: +---------

Hempel acquires Cap Couleurs Group’s store network in South-East France

World-leading coatings manufacturer, Hempel A/S, has acquired the Cap Couleurs Group’s store network in South-East France, maintaining Hempel’s segment leadership in the Var region and supporting its growth initiatives.Following an exclusive dialogue, Hempel has completed the acquisition of the Cap Couleurs Group’s store network in South-East France, supporting its strategy to double Hempel by 2025. This acquisition complements Hempel’s existing network of ten Renaulac stores in France. Hempel’s Double Impact strategy will be realised through both acquisitions and organic growth, as well as

Danicopan Phase III trial met primary endpoint

16 September 2022 07:10 BST Danicopan (ALXN2040) add-on to Ultomiris or Soliris met primary endpoint in ALPHA Phase III trial for patients with paroxysmal nocturnal haemoglobinuria who experience clinically significant extravascular haemolysis Interim results demonstrate statistically significant improvement compared to placebo in haemoglobin levels from baseline to week 12 A prespecified interim analysis of the ALPHA Phase III trial evaluating danicopan (ALXN2040), an investigational, oral factor D inhibitor, as an add-on to C5 inhibitor therapy Ultomiris (ravulizumab) or Soliris (

Evusheld positive CHMP opinion in EU

16 September 2022 07:05 BST Evusheld long-acting antibody combination recommended for approval in the EU for the treatment of COVID-19 Recommendation based on TACKLE Phase III treatment data showing reduced risk of severe COVID-19 or death AstraZeneca's Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting antibody combination, has been recommended for marketing authorisation in the European Union (EU) for the treatment of adults and adolescents (aged 12 years and older weighing at least 40 kg) with COVID‑19 who do not require supplemental oxygen and who are

Focus on safety in work environment

Safety in work environment is a priority for Assemblin, which annually conducts national safety campaigns throughout its operations. In Sweden, this year’s safety campaign will take place in connection with the “Håll Nollan” (Keep it at Zero) industry initiative’s safety drive on September, 20.Many of Assemblin’s employees work in hazardous work environments, and certain tasks are particularly risky. They may involve working at heights, hot work, sharp tools, risk of electrocution, receiving heavy goods or stress. Accordingly, safety in work environment is a high priority issue for

The subscription period in Brighter’s rights issue starts today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, SOUTH AFRICA, CANADA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Today, September 16, 2022, the subscription period for Brighter AB’s (publ) (“Brighter” or the “Company”) upcoming rights issue of units, which was announced on August 25, 2022 (the “Rights Issue”), begins. The subscription period in the Rights Issue runs from and including September 16, 2022, up to and including

Nirsevimab recommended for approval in EU by CHMP

16 September 2022 07:00 BST Beyfortus (nirsevimab) recommended for approval in the EU by CHMP for the prevention of RSV lower respiratory tract disease in infants  Recommendation is based on the Beyfortus clinical trial programme which demonstrated protection against RSV disease during the RSV season with a single dose If approved by the European Commission, Beyfortus would be the first preventative option for the broad newborn and infant population AstraZeneca and Sanofi's Beyfortus (nirsevimab) has been recommended for marketing authorisation in the European Union (EU) for the

Mycronic appoints Nomination Committee

The Nomination Committee for Mycronic’s 2023 Annual General Meeting has been appointed in accordance with the instructions for the Nomination Committee as decided by the 2022 Annual General Meeting.   The Nomination Committee comprises: Henrik Blomquist, Bure Equity Patrik Jönsson, SEB Funds Thomas Ehlin, The Fourth Swedish National Pension Fund Patrik Tigerschiöld, Chairman   The Nomination Committee represents 47.1 percent of votes and shares as of August 31, 2022. Shareholders who wish to submit proposals to the Nomination Committee are welcome to contact the

First notice of allowance of patent and top-line results from PK study of VAL001 available

Respiratorius announces that the patent application for the formulation of VAL001 has been allowed by a formal notice of allowance from Japan Patent Office. Respiratorius also announces that preliminary top-line results from the PK study with VAL001 are available.The patent application, claiming a novel and dedicated oral formulation of sodium valproate for pretreating cancer, has been allowed by the Japan Patent Office. The priority date of the patent application is 21 April 2016 and in force for at least 20 years from the priority date granting market exclusivity. The tailored

Composition of Kojamo plc’s Nomination Board

Kojamo plc Stock Exchange Release, 16 September 2022 at 9:00 a.m. EEST Composition of Kojamo plc’s Nomination Board Kojamo plc’s three largest shareholders have nominated the following members to the Shareholders’ Nomination Board: · Arve Regland, CFO, Heimstaden Bostad AB · Jouko Pölönen, CEO, Ilmarinen Mutual Pension Insurance Company · Risto Murto, CEO, Varma Mutual Pension Insurance Company In addition, Chairman of Kojamo’s Board of Directors, will serve as the Nomination Board’s expert member. The right to nominate representatives is vested with the three

Wallenstam makes recycling inventory in Älta

Wallenstam is entering into an agreement with the architecture and circular innovation firm Lendager to create the best possible conditions for recycling in the urban development project Mera Älta. Here, Wallenstam will built about 1,250 new apartments in a total of seven blocks.  The work has now begun with an initial resource mapping to gain an overview and an understanding of the resources that will be available during the development project.We are very happy about this collaboration – we regard the circular economy and recycling as an important part of the solution, offering the

SKF announces changes to Group Management

Gothenburg, 16 September 2022: SKF announces the appointment of Henry Wang as President, China and Northeast Asia. Henry is currently President of Alstom’s operations in China and was previously CEO of KUKA in China. From 1997-2019, Henry held a number of roles in SKF, including as Head of Industrial Sales in China. Henry has a Master of Business Administration from the University of Calgary and a Bachelor of Engineering from Shanghai Jiaotong University. Rickard Gustafson, President and CEO, says: “Henry’s leadership skills, experience and regional knowledge will help us

CO2 Capsol - First Half Year Results 2022

Oslo, Norway - 16 September 2022CO2 Capsol´s first half year results for 2022 was published today, 16 September2022.During the period, several important milestones were achieved:• The Company made an investment decision for its first CapsolGo™ demonstrationunit and signed a contract for its first deployment at Öresundskraft AB´sCombined Heat and Power plant in Helsingborg, Sweden.• The Company placed an order for a second CapsolGo™ unit to meet increasingdemand.• The Company entered into several collaborations for the promotion anddeployment of our carbon capture

Nordea Bank Abp: Repurchase of own shares on 15.09.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares15.09.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 15.09.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XHEL 250,000 9.65 2,411,275.00CEUX 250,000 9.64 2,409,749.24TQEX 43,902 9.63 422,942.99XSTO 250,000 9.63 2,407,112.38

Vicore provides an update on the ATTRACT-3 COVID-19 trial

· ATTRACT-3 did not meet its primary endpoint, reduction of all-cause mortality at 60 days · Lack of effect explained by new virus mutations · No safety signals detected   · The company will focus the development of C21 for the treatment of IPF and PAH Gothenburg, September 15, 2022 – Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (AT2R), today announces the top-line data from the ATTRACT-3 trial in hospitalized COVID-19 patients.  In ATTRACT-3[1], a global phase 3 trial,

Bictory Finance launches web3 domains on Concordium to simplify transactions on the blockchain

September 15, Zug, Switzerland - Bictory Finance , a web3 software technology company, tackling safety & regulatory problems across chains in the DeFi & NFT space, has launched the Concordium Name Service (CNS ), a wallet naming system that maps human-readable names to blockchain addresses for a more friendly on-chain experience. The Concordium Name Service (CNS) enables users to mint blockchain domains to replace the lengthy string of alphanumeric characters, which serves as wallet addresses, with human-readable and memorizable names, like john.

James Turner joins Teknos Group as Chief Communications Officer, member of TMT

On 1 September, James Turner has been appointed Teknos Group Chief Communications Officer. He is responsible for internal and external communications, including public affairs. James manages the Group Communications Team and supports communication teams and processes globally. He is a member of the Teknos Management Team (TMT).   James is a senior communicator with significant experience leading communications in global organisations."I'm thrilled to join the Teknos family. Together, we'll tell our story so that everyone knows how 'We make the world last longer' and why it's so important.

There are no items matching the current filter
There are no more items matching the current filter
Back to top